Advanced search
Publication Cover
Cancer Management and Research Volume 10, 2018 - Issue
Submit an article Journal homepage
121
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification

Kun Ke1 The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China, [email protected];2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected]
,
Geng Chen2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];4 School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, China
,
Zhixiong Cai2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];4 School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, China
,
Yanbing Huang1 The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China, [email protected];2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected]
,
Bixing Zhao2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected]
,
Yingchao Wang2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected]
,
Naishun Liao2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected]
,
Xiaolong Liu2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected]
,
Zhenli Li2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected]Correspondence[email protected] [email protected]
&
Jingfeng Liu1 The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China, [email protected];2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];3 The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, China, [email protected]; [email protected];5 Liver Disease Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China, [email protected]Correspondence[email protected] [email protected]
 show all
Pages 5291-5302 | Published online: 05 Nov 2018

References

  • TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
  • FornerAReigMBruixJHepatocellular carcinomaLancet2018391101271301131429307467
  • MaluccioMCoveyARecent progress in understanding, diagnosing, and treating hepatocellular carcinomaCA Cancer J Clin201262639439923070690
  • GluerAMCoccoNLaurenceJMSystematic review of actual 10-year survival following resection for hepatocellular carcinomaHPB201214528529022487065
  • MaidaMOrlandoECammàCCabibboGStaging systems of hepatocellular carcinoma: a review of literatureWorld J Gastroenterol201420154141415024764652
  • MarreroJAKudoMBronowickiJPThe challenge of prognosis and staging for hepatocellular carcinomaOncologist201015Suppl 4233321115578
  • ToyodaHKumadaTOsakiYStaging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markersClin Gastroenterol Hepatol20064121528153617162244
  • ChapiroJGeschwindJFHepatocellular carcinoma: have we finally found the ultimate staging system for HCC?Nat Rev Gastroenterol Hepatol201411633433624798199
  • YuanSWangJYangYThe Prediction of Clinical Outcome in Hepatocellular Carcinoma Based on a Six-Gene Metastasis SignatureClin Cancer Res201723128929727449498
  • NaultJCDe ReynièsAVillanuevaAA hepatocellular carcinoma 5-gene score associated with survival of patients after liver resectionGastroenterology2013145117618723567350
  • SpeirMLZweigASRosenbloomKRThe UCSC Genome Browser database: 2016 updateNucleic Acids Res201644D1D717D72526590259
  • VillaECritelliRLeiBNeoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective studyGut201665586186925666192
  • ChiangDYVillanuevaAHoshidaYFocal gains of VEGFA and molecular classification of hepatocellular carcinomaCancer Res200868166779678818701503
  • MínguezBHoshidaYVillanuevaAGene-expression signature of vascular invasion in hepatocellular carcinomaJ Hepatol20115561325133121703203
  • LimHYSohnIDengSPrediction of disease-free survival in hepatocellular carcinoma by gene expression profilingAnn Surg Oncol201320123747375323800896
  • RousseeuwPJSilhouettes: A graphical aid to the interpretation and validation of cluster analysisJ Comput Appl Math198720205365
  • TusherVGTibshiraniRChuGSignificance analysis of microarrays applied to the ionizing radiation responseProc Natl Acad Sci U S A20019895116512111309499
  • TibshiraniRHastieTNarasimhanBChuGDiagnosis of multiple cancer types by shrunken centroids of gene expressionProc Natl Acad Sci U S A200299106567657212011421
  • KamburovAStelzlULehrachHHerwigRThe ConsensusPathDB interaction database: 2013 updateNucleic Acids Res201341Database issueD793D80023143270
  • LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) MethodMethods200125440240811846609
  • KaplanELMeierPNonparametric Estimation from Incomplete ObservationsJ Am Stat Assoc195853282457481
  • McHughMLInterrater reliability: the kappa statisticBiochem Med2012223276282
  • ZhouLRuiJAWangSBChenSGQuQThe significance of serum AFP cut-off values, 20 and 400 ng/mL in curatively resected patients with hepatocellular carcinoma and cirrhosis might be of differenceHepatogastroenterology20125911584084322469729
  • AravalliRNSteerCJCressmanENMolecular mechanisms of hepatocellular carcinomaHepatology20084862047206319003900
  • MalumbresMBarbacidMCell cycle, CDKs and cancer: a changing paradigmNat Rev Cancer20099315316619238148
  • NwosuZCMeggerDAHammadSIdentification of the Consistently Altered Metabolic Targets in Human Hepatocellular CarcinomaCell Mol Gastroenterol Hepatol201742e301303323
  • McIntyreAPatiarSWigfieldSCarbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapyClin Cancer Res201218113100311122498007
  • ZhouSLDaiZZhouZJOverexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinomaHepatology20125662242225422711685
  • HongXSongRSongHPTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesisGut201463101635164724352616
  • NgKTQiXKongKLOverexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinomaEur J Cancer201147152299230521683576
  • MusaJAynaudMMMirabeauODelattreOGrünewaldTGMYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesisCell Death Dis201786e289528640249
  • LiuYYangLAnHHigh expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinomaSci Rep201551695426599282

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.